Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saline Injection Versus Ultrasound Guided Cortisone Injection in HFPI
NCT07255248Phase 4Recruiting
- Sponsor
- Boston Children's Hospital
- Start
- Mar 2026
- Primary completion
- Nov 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone, lidocaine in Hoffa's disease (HD), sponsored by Boston Children's Hospital. Started Mar 2026; status: recruiting.
02
Drugs
methylprednisolonelidocaine
03
Conditions
Hoffa's disease (HD)
Beyond the preview
Go deeper on NCT07255248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07255248.